Zollinger Ellison Syndrome Therapeutics
1. Aciphex patent expiration
Treatment: Treatment of peptic ulcers
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5045552 | WAYLIS THERAP | Pyridine derivatives having anti-ulcerative activity |
May, 2013
(12 years ago) | |
|
US5045552 (Pediatric) | WAYLIS THERAP | Pyridine derivatives having anti-ulcerative activity |
Nov, 2013
(12 years ago) | |
Drugs and Companies using RABEPRAZOLE SODIUM ingredient
Market Authorisation Date: 29 May, 2002
Dosage: TABLET, DELAYED RELEASE
How can I launch a generic of ACIPHEX before it's drug patent expiration?
More Information on Dosage
ACIPHEX family patents
